Katrina M Pollock Selected Research

Katrina M Pollock Research Topics

Disease

10	COVID-19 11/2023 - 01/2020
7	Infections 12/2023 - 10/2019
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023 - 01/2023
4	HIV Infections (HIV Infection) 01/2021 - 09/2015
3	Human Influenza (Influenza) 12/2023 - 10/2019
2	Breakthrough Infections 10/2023 - 01/2023
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2021
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
2	Cough 10/2021 - 01/2021
2	Fever (Fevers) 10/2021 - 01/2021
1	Trachoma 04/2024
1	Critical Illness (Critically Ill) 11/2023
1	Thrombosis (Thrombus) 01/2023
1	Virus Diseases (Viral Diseases) 01/2022
1	Chills 01/2020
1	Headache (Headaches) 01/2020
1	Pain (Aches) 01/2020
1	Viremia 02/2018
1	Coinfection 01/2016
1	Necrosis 01/2016
1	Opportunistic Infections (Opportunistic Infection) 09/2015
1	Tuberculosis (Tuberculoses) 09/2013
1	Latent Tuberculosis 09/2013
1	Tuberculoma 01/2008
1	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2008

Drug/Important Bio-Agent (IBA)

9	VaccinesIBA 04/2024 - 01/2021
5	ChAdOx1 nCoV-19IBA 10/2021 - 01/2020
4	COVID-19 VaccinesIBA 11/2023 - 01/2023
3	Immunoglobulin G (IgG)IBA 04/2024 - 10/2019
3	AntibodiesIBA 04/2024 - 01/2023
3	Infliximab (Remicade)FDA Link 11/2023 - 01/2023
3	mRNA VaccinesIBA 10/2023 - 02/2022
3	RNA (Ribonucleic Acid)IBA 10/2022 - 02/2018
3	Nucleic AcidsIBA 10/2021 - 01/2021
2	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2023 - 10/2019
2	tofacitinibIBA 11/2023 - 01/2023
2	AntigensIBA 10/2022 - 09/2015
2	MenACWYIBA 10/2021 - 01/2020
1	Liposomes (Liposome)IBA 04/2024
1	2-mercaptopurineIBA 11/2023
1	Angiotensin Receptor AntagonistsIBA 11/2023
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2023
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 11/2023
1	(N- Ac- His(1)- Nle(17)- Arg(20,21)- Ala(26))- vasoactive intestinal peptideIBA 10/2023
1	Janus Kinase InhibitorsIBA 10/2023
1	Combined VaccinesIBA 10/2023
1	Glycoproteins (Glycoprotein)IBA 10/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OHIBA 01/2023
1	Neutralizing AntibodiesIBA 01/2023
1	IntegrinsIBA 01/2023
1	vedolizumabIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	BNT162 VaccineIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Lipid NanoparticlesIBA 02/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	Interleukin-2 (IL2)IBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	CytokinesIBA 01/2016
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 09/2013
1	Biomarkers (Surrogate Marker)IBA 09/2013

Therapy/Procedure

4	Therapeutics 11/2023 - 01/2008
1	Biological Therapy 01/2023
1	Intramuscular Injections 01/2020
1	Art Therapy 10/2019